Publication:
Posterior Subcapsular Cataracts in Patients Treated with Inhaled Steroids

Simple item page
dc.contributor.authorErkan D.
dc.contributor.authorOge I.
dc.contributor.authorErkan L.
dc.date.accessioned2020-06-21T09:19:32Z
dc.date.available2020-06-21T09:19:32Z
dc.date.issued1996
dc.departmentOMÜen_US
dc.department-tempErkan, D., Department of Ophthalmology, School of Medicine, Ondokuz Mayis University, Samsun, Turkey -- Oge, I., Department of Ophthalmology, School of Medicine, Ondokuz Mayis University, Samsun, Turkey -- Erkan, L., Department of Ophthalmology, School of Medicine, Ondokuz Mayis University, Samsun, Turkey --en_US
dc.description.abstractPosterior subcapsular cataract formation as a risk of steroid therapy is generally assumed to be much lower with inhaled steroids than with systemic steroids. In this study, slitlamp examinations were done on 14 adult asthmatic patients who were taking inhaled steroids (beclomethasone diproprionate) combined with intermittent short reducing courses of oral steroids. The mean age of the patients was 39.289 ± 2.99 (SEM), the mean current daily dose of inhaled steroid was 1089.29 ± 106.80 (SEM) ?g and the mean duration of inhaled steroid therapy was 46.79 ± 2.85 (SEM) months. The prevalence of posterior subcapsular cataracts was 7.14%.en_US
dc.identifier.endpage46en_US
dc.identifier.issn1300-2996
dc.identifier.issue1en_US
dc.identifier.startpage41en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/3065
dc.identifier.volume13en_US
dc.language.isoenen_US
dc.relation.journalOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBeclomethasoneen_US
dc.subjectInhaled Steroidsen_US
dc.subjectPosterior Subcapsular Cataracten_US
dc.titlePosterior Subcapsular Cataracts in Patients Treated with Inhaled Steroidsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu